Lv7
3360 积分 2022-09-22 加入
OP26 Programmable probiotic local delivery of anti-TNF-α nanobody to alleviate DSS-induced colitis
11天前
已完结
Phytochemicals as potential therapeutic agents for inflammatory bowel disease: a comprehensive review
27天前
已完结
Inflammatory bowel disease in Canada: temporal trends in the incidence and prevalence over the past 30 years
27天前
已关闭
Triple-Functional Probiotics with Intracellularly Synthesized Selenium Nanoparticles for Colitis Therapy by Regulating the Macrophage Phenotype and Modulating Gut Microbiota
1个月前
已完结
Mucoadhesive and Self-Assembled Chitosan Oligosaccharide-Glycyrrhizin Nanoparticle for Oral Nanotherapeutic in Inflammatory Bowel Disease
1个月前
已完结
Gut microbiome in IBD: past, present and the future
1个月前
已完结
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
2个月前
已完结
Inflammatory bowel disease has no borders: engaging patients as partners to deliver global, equitable and holistic health care
2个月前
已完结
New Insight into Plasmid-Driven T7 RNA Polymerase in Escherichia coli and Use as a Genetic Amplifier for a Biosensor
4个月前
已完结
Delivery of Encapsulated Intelligent Engineered Probiotic for Inflammatory Bowel Disease Therapy
4个月前
已完结
皖公网安备34019202002308
